PJ Fialkow - Annual Review of Medicine, 1979 - Annual Reviews Despite the frequency of cancer and years of intensive research, the causes of
only a few human neoplasms are known. Also poorly understood are the mechanisms
that determine whether a tumor will be benign or malignant, the processes ... Cited by 481 - Related articles - All 4 versions
- ►rupress.org [PDF] H Kubagawa, LB Vogler, JD Capra, ME … - Journal of Experimental Medicine, 1979 - jem.rupress.org From the Cellular Immunobiology Unit of the Tumor Institute, Departments of
Pediatrics, Medicine and Microbiology, The Comprehensive Cancer Center,
University of Alabama in Birmingham, Birmingham, Alabama 35294; and the ... Cited by 152 - Related articles - All 2 versions
- ►hematologylibrary.org [PDF] Y Gazitt, CC Reading, R Hoffman, A Wickrema, … - Blood, 1995 - bloodjournal.hematologylibrary.org UTOLOGOUS TRANSPLANTATION is now fre- quently used in the treatment of patients
with multiple myeloma (MM).'" A major advance in autologous trans- plantation
was the observation that peripheral blood stem cells (PBSCs), mobilized ... Cited by 107 - Related articles - BL Direct - All 4 versions
CR Taylor, DP Bchir, RL Davis, R Russell, RJ … - CA A Cancer Journal for Clinicians - interscience.wiley.com Paraffin sections of surgical and autopsy material from 24 cases of primary CNS
lymphoma were examined for the presence of cytoplasmic immunoglobulin by an
immunoperoxidase technique. Definite staining for cytoplasmic ... Cited by 96 - Related articles - All 2 versions
- ►hematologylibrary.org [PDF] TM Grogan, BG Durie, C Lomen, C Spier, DP … - Blood, 1987 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 71 - Related articles - All 5 versions
JL Preud'Homme, M Klein, S Labaume, M … - Eur J Immunol, 1977 - interscience.wiley.com Twenty-five to 30 % of blood lymphocytes from a myeloma patient with an IgGl(k)
protein with antibody activity to horse 2 -macroglobulin ( 2M) reacted with
purified IgG from a rabbit antiserum to the idiotypic determinants of this ... Cited by 62 - Related articles - All 2 versions
G Holm, H Mellstedt, D Pettersson, R … - Immunological reviews, 1977 - ncbi.nlm.nih.gov 1: Immunol Rev. 1977;34:139-64. Idiotypic immunoglobulin structures on blood
lymphocytes in human plasma cell myeloma. Holm G, Mellstedt ... Cited by 63 - Related articles
M Michallet, T Philip, I Philip, H Godinot, C … - Experimental Hematology, 2000 - Elsevier Twenty-three patients were transplanted. Engraftment data in the melphalan + TBI
cohorts confirmed that HSC doses above the threshold dose of 0.8 × 10 6 CD34 +
Thy1 + HSCs/kg provided prompt engraftment (absolute neutrophil count >0.5 ... Cited by 57 - Related articles - BL Direct - All 4 versions
- ►nih.gov [PDF] RG Hoover, S Hickman, HM Gebel, N Rebbe, … - Journal of Clinical Investigation, 1981 - pubmedcentral.nih.gov Page 1. Expansion of Fc Receptor-Bearing T Lymphocytes in Patients with
Immunoglobulin G and Immunoglobulin A Myeloma RICHARD G. HOOVER ... Cited by 46 - Related articles - All 5 versions
H Mellstedt, M Bjorkholm, G Holm - Acta Med Scand, 1977 - interscience.wiley.com ABSTRACT. Thirty-two consecutive, previously untreated patients with plasma cell
myeloma were treated with 4-day courses of melphalan (0.25 mg/kg/day) and
prednisolone (2 mg/kg/day) every sixth week. The observation period ranged ... Cited by 44 - Related articles - All 2 versions